Ministry of Health announces agreement with Moderna to acquire 10.8 million doses







The Minister of Health, Fernando Ruiz, announced on Tuesday that the National Government had reached an agreement with the Moderna pharmaceutical company for the supply of vaccines against covid-19 within the framework of the National Vaccination Plan.


(You may be interested in: Where is the pandemic going in the country? Experts respond)

The negotiation consists of 10.8 million biologicals whose first delivery (one million ) will be carried out in the first quarter of the year, 6 million doses during the second
quarter and 3.8 million doses during the third quarter.

These doses will be used to complete reinforcements, complete schemes and first doses. Ruiz Gómez recalled that the Moderna vaccine was developed with the mRNA platform and is authorized in Colombia for use in people over 12 years of age and as a booster dose for people over 12 years of age. 18.

For now there will be no fourth dose in Colombia, says Ministry of Health
Covid-19 pandemic “is far from over”, says WHO

It is worth mentioning that those over 18 years of age should go for a booster dose four months after the second dose, according to the guidelines of the Ministry of Health.

In the midst of the negotiation, Román Saglio, Senior Director of Commercial Alliances for Moderna in Latin America, added that Colombia was the first country in the region with which an agreement was reached for the distribution of vaccines from the Moderna laboratory , which is about to celebrate its first anniversary.

In this way, as of February 6, a total of 73,325,312 doses have been applied in the country.

(Keep reading : I already had covid-19: how many more times can I get it again?)

Ruiz Gómez pointed out that Colombia probably has the most diverse portfolio of vaccines in the region, with 105,203,700 vaccines acquired, of which of which 67,804,020 correspond to the bilateral mechanism, 20,000,000 to the Covax multilateral mechanism and 17,673,000 doses to donations.